can glp 1 hurt your kidneys GLP-1 drugs cause pancreatitis, kidney injury, bowel obstruction, ministry warns Renal effects of GLP-1 receptor

Cummings DE, Purnell JQ, Frayo RS, Schimidova K, Wisse BE, Weigle DS

Current market leaders include Novo and Eli Lilly LLY, with treatments such as Ozempic, Wegovy, Mounjaro, and Zepbound addressing both diabetes and obesity

Regular follow-up appointments should be scheduled according to individual needs, typically every 3-6 months during the first year of GLP-1 therapy, with thyroid function testing as clinically indicated

Because the body will have more fat than muscle and be less effective at burning calories, weight loss is probably just temporary

Starting doses of Wegovy and Zepbound will cost the Medicare and Medicaid programs $350 a month and decrease in cost over a two-year period